Replies to post #606832 on NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

Roman516, please read this post and let me know if this answers your questions:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172272137

[georgebailey]

Roman sorry 55 minute mark. ATL opined the 20-25% LT survival referenced the 600+ patients treated with DCVax.

[Survivor2012]

Roman516,
I heard the same numbers mentioned -- can a Phase III trial TLD be revised? We were at 13% v. 5.7% -- right. She basically doubled the OS number, unless she was referencing something different.